Western tradition · Flavonoid

Quercetin 槲皮素

A widespread dietary flavonoid, studied as a senolytic partner (with dasatinib) and anti-inflammatory.

135ClinicalTrials.gov matched
274PubMed RCT records
219Meta-analysis records
294+PubMed records
QuercetinKey active compound

Data definition. Matched records include all indexed medical endpoints for this intervention — not only longevity. Longevity-relevant records are screened separately and cited in the evidence summary below. Counts are matched-record volumes, not de-duplicated trials and not efficacy claims.

Origin & tradition

Not traditional as an isolate, though quercetin-rich foods (onions, capers) are dietary staples.

Why longevity buyers care

Key active: Quercetin (flavonoid).

Quercetin modulates inflammation and, combined with dasatinib (D+Q), is the most-studied senolytic regimen in early human trials for senescence-associated conditions.

Effect summary

Studied health outcomes

Editorial summary — This table is curated by hand from published research consensus, not automatically calculated from our trial database. Grades reflect our interpretation of the literature. Treat as a starting point, not a definitive verdict. See the Evidence panel below for the underlying trial and paper counts sourced directly from ClinicalTrials.gov and PubMed.
Health outcomeEffectMagnitudeGrade
Inflammation (CRP)↓DecreasesMinorB
Systolic blood pressure↓DecreasesMinorB
Allergy symptoms (histamine)↓DecreasesModerateB
Senescent cell burden — Mostly preclinical; one early human pilot↓DecreasesMinorD
LDL oxidation↓DecreasesMinorC
Aerobic endurance↑IncreasesMinorC

Grade: A = robust RCTs · B = several RCTs / meta-analysis · C = limited or mixed RCTs · D = observational or early data

Dosage guidance

How Quercetin is typically used

Typical dose
500–1,000 mg/day
Form
capsule; Quercefit (phytosome) preferred for absorption
Timing
with meals

Standard quercetin has poor bioavailability. Quercefit (quercetin-phospholipid complex) is ~20× better absorbed. For senolytic use, intermittent high-dose protocols (e.g. 1,000 mg × 2 days, with Dasatinib off-label) are under investigation.

Informational only — not a prescription or personalised medical advice. Consult a qualified clinician before starting any supplement or medication.

Evidence summary

What the research actually says

70Evidence confidence
Extensive human-trial evidence274 randomized controlled trials · 219 meta-analyses / systematic reviews

Early human senolytic trials (D+Q); anti-inflammatory data

Quercetin modulates inflammation and, combined with dasatinib (D+Q), is the most-studied senolytic regimen in early human trials for senescence-associated conditions.

135registered clinical trials reference this intervention
    3selected from 294+ PubMed papers (longevity / aging angle)
    Key active: Quercetin (flavonoid).

    According to PubMed and ClinicalTrials.gov: trial counts from ClinicalTrials.gov, peer-reviewed literature from PubMed. Counts auto-refresh weekly; last checked 2026-11-16. They include trials across many endpoints, not only longevity.

    Informational only — not medical advice, a treatment claim, or a substitute for a qualified clinician. Evidence strength varies; we show mixed and null results on purpose.

    Suppliers

    No Quercetin suppliers listed yet

    Tell us what you need and we will source suppliers for you.

    Request sourcing help